These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 339438

  • 1. The use of antilymphoblast globulin in the treatment of renal allograft rejection: a double-blind, randomized study.
    Howard RJ, Condie RM, Sutherland DE, Simmons RL, Najarian JS.
    Transplantation; 1977 Dec; 24(6):419-23. PubMed ID: 339438
    [Abstract] [Full Text] [Related]

  • 2. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP, Johnson CP, Callaluce RD, Browne BJ, Zhu YR, Roza AM, Adams MB.
    Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
    [Abstract] [Full Text] [Related]

  • 3. Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors.
    Najarian JS, Simmons RL, Condie RM, Thompson EJ, Fryd DS, Howard RJ, Matas AJ, Sutherland DE, Ferguson RM, Schmidtke JR.
    Ann Surg; 1976 Sep; 184(3):352-68. PubMed ID: 786192
    [Abstract] [Full Text] [Related]

  • 4. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G, Walsh G, Deshpande P, Koffman G.
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [Abstract] [Full Text] [Related]

  • 5. The effect of serum ALG concentrations on results following renal transplantation.
    Howard RJ, Condie RM, Sutherland DE, Simmons RL, Najarian JS.
    Ann Surg; 1977 Nov; 186(5):619-24. PubMed ID: 335988
    [Abstract] [Full Text] [Related]

  • 6. A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation.
    Novick AC, Braun WE, Steinmuller D, Buszta C, Greenstreet R, Kiser W.
    Transplantation; 1983 Feb; 35(2):175-9. PubMed ID: 6338636
    [Abstract] [Full Text] [Related]

  • 7. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW, Jendrisak MD, So SK, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T.
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [Abstract] [Full Text] [Related]

  • 8. Effect of delayed graft function and ALG on the circaseptan (about 7-day) rhythm of human renal allograft rejection.
    Besarab A, Wesson L, Jarrell B, Burke JF.
    Transplantation; 1983 Jun; 35(6):562-6. PubMed ID: 6346597
    [Abstract] [Full Text] [Related]

  • 9. Low-dose maintenance prednisone and antilymphoblast globulin for the treatment of acute rejection. A steroid-sparing approach to immunosuppressive therapy.
    Streem SB, Novick AC, Braun WE, Steinmuller D, Greenstreet R.
    Transplantation; 1983 May; 35(5):420-4. PubMed ID: 6342219
    [Abstract] [Full Text] [Related]

  • 10. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR, Blamey RW, Briggs JD, Castro JE, Hamilton DN, Knapp MS, Salaman JR, Sells RA, Williams G, Gowans JL, Peto R, Richards S, Phillips AW, Weinberg AL, Freestone DS.
    Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
    [Abstract] [Full Text] [Related]

  • 11. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
    Veremis SA, Maddux MS, Pollak R, Kline SS, Mozes MF.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 15; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 14. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Jun 15; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 15. Acute rejection episodes after renal transplantation in children.
    Hoyer PF, Offner G, Brodehl J.
    Clin Nephrol; 1983 Feb 15; 19(2):61-6. PubMed ID: 6340876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin.
    Novick AC, Khauli RB, Braun WE, Steinmuller D, Cunningham R, Buszta C, Goormastic M.
    J Urol; 1984 Apr 15; 131(4):636-40. PubMed ID: 6368866
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.